Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (SPM) (manufacturer control # DK-1577272925-2015001177) on 21-DEC-2015. Case received from a physician via health authority on 17-Dec-2015 under reference number DK-DKMA-WBS-0002100. A 12-year-old female adolescent patient received GARDASIL, batch number unknown via intramuscular route in May-2012. The patient experienced Joint pain in JUL-2012, Weight - gaining and then loosing in JUL-2012, Syncope on an unknown date, Abdominal pain on an unknown date and Sleep disorder on an unknown date. The patient had received previously two doses of GARDASIL (not reported dates). Onset after third dose (May 2012) approx. 2 months after administration. She describes that she had developed joint pain and that her weight is unstable she gain and she loose. After the other reactions. She does not remember the dates of the first 2 doses. Additional investigations included Tilt Table Test orthostatic intolerance on an unknown date. The patient''s outcome was reported as Not Recovered/Not Resolved.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166